Skip to main content
AMA Journal of Ethics®
Illuminating the Art of Medicine

Main navigation

  • Issues
  • Articles
  • Cases
  • Art
  • Multimedia
  • CME
  • Topics
  • For Authors
  • Call for Papers
  • Call for Artwork
  • Call for Editorial Fellows
  • Art Collaborations
  • Register for Sep 10 Grand Rounds
  • En Español

Featured Content

Case and Commentary
Apr 2025

¿Cómo deberían proteger los miembros del equipo de cirugía a los pacientes que están privados de libertad de la vigilancia o intrusión de los oficiales del centro penitenciario?

Anna Lin, MD and Mallory Williams, MD, MPH
Case and Commentary
Feb 2025

¿Cómo se debe describir y tratar el dolor causado por la colocación del DIU?

Veronica Hutchison, MD and Eve Espey, MD, MPH

Articles

Article Types
Topics
Core Competencies
Specialties
Language
Reset
  • msoc1-peer2-2002
    Medicine and Society
    Feb 2020

    How Should Low- and Middle-Income Countries Motivate Equity in Cancer Prevention and Control?

    Justin M. List, MD, MAR, MSc and Jeremy M. O’Connor, MD, MHS
    Government and public-private coalitions have important roles in cancer surveillance in LMICs.
    AMA J Ethics. 2020;22(2):E147-155. doi: 10.1001/amajethics.2020.147.
  • artm2-2002
    Art of Medicine
    Feb 2020

    Girl and Rooster

    Ayotunde Ayobello, MD
    A fearless child inspires compassion, particularly regarding our clinical, political, and ethical orientation to ongoing practices of separating children from parents at the US southern border.
    AMA J Ethics. 2020;22(2):E166-167. doi: 10.1001/amajethics.2020.166.
  • cscm3-2020
    Case and Commentary
    Feb 2020

    When Is a Suboptimal Approach to Cancer Screening Better Than None?

    Ramy Sedhom, MD and Bishal Gyawali, MD, PhD
    Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach.
    AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93.
  • code1-2002
    AMA Code Says
    Feb 2020

    AMA Policies and Code of Medical Ethics’ Opinions Related to Cancer Prevention in Low- and Middle-Income Countries

    Andi Sirokman
    Redirecting focus from treatment to prevention is a global public health imperative.
    AMA J Ethics. 2020;22(2):E112-115. doi: 10.1001/amajethics.2020.112.
  • pfor2-2002
    Policy Forum
    Feb 2020

    How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?

    Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD
    Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights.
    AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135.
  • cscm1-2002
    Case and Commentary
    Feb 2020

    How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs?

    Paul Ndebele, PhD and Sithembile Ruzario, MSc
    Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake.
    AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76.
  • stas1-2002
    State of the Art and Science
    Feb 2020

    Why Consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income Countries?

    Victoire Fokom Defo, MD and Joël Fokom Domgue, MD, MPH
    HPV tests are alternatives to Pap smear screening that enable women to self-collect specimens and might be the best cervical cancer prevention strategy for many.
    AMA J Ethics. 2020;22(2):E116-125. doi: 10.1001/amajethics.2020.116.
  • msoc2-2002
    Medicine and Society
    Feb 2020

    How Should Biobanking Be Governed in Low-Resource Settings?

    Aminu Yakubu, Nchangwi Syntia Munung, and Jantina De Vries, PhD
    African cancer research is embedded in underresourced health care infrastructures, illuminating ethical questions about benefit sharing and governance.
    AMA J Ethics. 2020;22(2):E156-163. doi: 10.1001/amajethics.2020.156.
  • hlaw1-2002
    Health Law
    Feb 2020

    Can International Patent Law Help Mitigate Cancer Inequity in LMICs?

    Srividya Ragavan, SJD and Amaka Vanni, PhD
    Inequity makes it imperative to consider how trade and patent policies influence international patients’ access to treatment and prevention.
    AMA J Ethics. 2020;22(2):E102-111. doi: 10.1001/amajethics.2020.102.
  • artm1-2002
    Art of Medicine
    Feb 2020

    Risks, Benefits, and Conundrums of Cancer Screening

    Nick Love, PhD
    A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs.
    AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164.

Pagination

  • First page « First
  • Previous page ‹ Prev
  • …
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Current page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • …
  • Next page Next ›
  • Last page Last »
AMA Journal of Ethics®
Illuminating the Art of Medicine

Footer menu

  • About
  • Conditions of Use
  • Privacy Policy
  • Website Accessibility
  • FAQ
  • Contact
American Medical Association

Email Signup


We do not share email addresses and will only use yours to send new content alerts. (Add [email protected] to your contacts to help ensure receipt.)
Copyright 2025 American Medical Association. All Rights Reserved. ISSN 2376-6980